NONOF - One in eight U.S. adults admits to GLP-1 usage as public awareness climbs
2024-05-10 10:16:35 ET
More on Eli Lilly, Novo Nordisk, etc.
- Eli Lilly: Great Time To Divest Before It Potentially Crashes
- Eli Lilly Remains Expensive Here - Minimal Margin Of Safety
- The FTC Cracks Down On Novo Nordisk's Ozempic
- Dividend Roundup: Eli Lilly, American Express, Microsoft, Delta Air Lines, and more
- Novo Nordisk, Flagship to develop next-generation obesity drugs